|
Index of reports
> Cases resulting in other serious reactions (320)
> Cases with Blood Creatine Phosphokinase Increased (21)
Below is the selection of adverse event reports related to Norvasc (Amlodipine) that includes cases resulting in other serious reactions where reactions include blood creatine phosphokinase increased.
Adverse event in 50 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Australia on 2007-10-19
Patient: 50 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Abdominal Pain Upper
Suspect drug(s):
Caduet
Dosage: text:5mg/40mg
Start date: 2007-08-06
End date: 2007-10-06
Lipitor
Norvasc
Other drugs received by patient: Avapro; Acetylsalicylic Acid
Adverse event in 70 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-07-27
Patient: 70 year old female
Adverse reactions / side effects: Back Pain, Blood Creatine Phosphokinase Increased, Dehydration
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Warfarin Sodium; Olmesartan Medoxomil; Artist
Adverse event in 69 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-07-03
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 81 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-06-22
Patient: 81 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Blopress
Dosage: daily dose:8mg-freq:daily
Administration route: Oral
Blopress
Dosage: daily dose:8mg-freq:daily
Administration route: Oral
Start date: 2007-04-05
End date: 2007-04-07
Norvasc
Dosage: daily dose:5mg-freq:daily
Administration route: Oral
Norvasc
Dosage: daily dose:5mg-freq:daily
Administration route: Oral
Start date: 2007-04-05
End date: 2007-04-07
Adverse event in male receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-06-15
Patient: male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Intentional Overdose, Nausea, Suicide Attempt, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Ibuprofen
Administration route: Oral
Norvasc
Administration route: Oral
Indication: Hypertension
Start date: 2006-05-01
End date: 2007-05-01
Norvasc
Dosage: daily dose:120mg-freq:once
Administration route: Oral
Other drugs received by patient: Luvox; Paxil; Lomerizine Hydrochloride
Adverse event in 69 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-06-06
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 81 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-06-05
Patient: 81 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Myoglobin Blood Increased
Suspect drug(s):
Norvasc (Amlodipine)
Adverse event in 81 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-05-29
Patient: 81 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Myoglobin Blood Increased
Suspect drug(s):
Norvasc (Amlodipine)
Adverse event in 81 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-05-24
Patient: 81 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Blopress
Dosage: daily dose:8mg-freq:daily
Administration route: Oral
Blopress
Dosage: daily dose:8mg-freq:daily
Administration route: Oral
Start date: 2007-04-05
End date: 2007-04-07
Norvasc
Dosage: daily dose:5mg-freq:daily
Administration route: Oral
Norvasc
Dosage: daily dose:5mg-freq:daily
Administration route: Oral
Start date: 2007-04-05
End date: 2007-04-07
Adverse event in 69 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-05-23
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Muscle Twitching, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Oedema, Blood Sodium Increased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 81 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-05-08
Patient: 81 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Blopress
Dosage: daily dose:8mg-freq:daily
Administration route: Oral
Norvasc
Dosage: daily dose:5mg-freq:daily
Administration route: Oral
Adverse event in 69 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-04-30
Patient: 69 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Adverse event in 81 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-04-26
Patient: 81 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Blopress
Dosage: daily dose:8mg-freq:daily
Administration route: Oral
Norvasc
Dosage: daily dose:5mg-freq:daily
Administration route: Oral
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-04-26
Patient: female, weighing 46.0 kg (101.2 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Merislon; Stomin A; Atarax; Grandaxin
Adverse event in 81 year old female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-04-18
Patient: 81 year old female
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Blopress
Adverse event in 50 year old male receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-04-18
Patient: 50 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Micardis
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-04-17
Patient: female, weighing 46.0 kg (101.2 pounds)
Adverse reactions / side effects: White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Merislon; Stomin A; Atarax; Grandaxin
Adverse event in female receiving Norvasc (Amlodipine)
Reported by a consumer/non-health professional from Korea, Republic of on 2007-04-04
Patient: female
Adverse reactions / side effects: Myalgia, Hyperlipidaemia, Blood Creatine Phosphokinase Increased
Suspect drug(s):
Caduet
Dosage: text:5/10mg
Administration route: Oral
Indication: Hypertension
Caduet
Indication: Hyperlipidaemia
Norvasc
Indication: Hypertension
Adverse event in male receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-03-22
Patient: male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased
Suspect drug(s):
Norvasc (Amlodipine)
Other drugs received by patient: Micardis
Adverse event in 67 year old male receiving Norvasc (Amlodipine)
Reported by a physician from Japan on 2007-03-09
Patient: 67 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased
Suspect drug(s):
Norvasc (Amlodipine)
Adverse event in 64 year old male receiving Norvasc (Amlodipine)
Reported by a physician from United States on 2007-02-13
Patient: 64 year old male
Adverse reactions / side effects: Urinary Tract Obstruction, Blood Creatine Phosphokinase Increased, Renal Failure, Rhabdomyolysis, Urinary Tract Infection, Hepatic Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Casodex
Administration route: Oral
Coumadin
Crestor
Administration route: Oral
Floxmax
Lotensin
Norvasc
|
